As the rising cost of prescription medications in the United States becomes an increasing barrier for millions of people, how ...

An exploration into how flawed incentives and contractual loopholes between manufacturers and pharmacy benefit managers ...

Reintroduction of the MFN model. The Trump Administration has revived the most-favored nation (MFN) drug pricing model as a seven-year test, which would tie US drug prices to the lowest prices paid by ...

In the second part of her Pharma Commerce video interview, Kirsten Newquist, Identiv’s CEO, describes why this technology is essential for pharmaceutical safety and efficacy.